Unmasking the COVID-19 pandemic prevention gains: excess mortality reversal in 2022.

COVID-19 Control measures Harvesting effect Health policy Mortality displacement Non-pharmaceutical interventions Post-pandemic transition period Public health interventions

Journal

Public health
ISSN: 1476-5616
Titre abrégé: Public Health
Pays: Netherlands
ID NLM: 0376507

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 11 03 2023
revised: 11 07 2023
accepted: 02 08 2023
medline: 25 9 2023
pubmed: 7 9 2023
entrez: 6 9 2023
Statut: ppublish

Résumé

The purpose of this study was to assess the long-term effectiveness of COVID-19 pandemic prevention measures in saving lives after European governments began to lift restrictions. Excess mortality interrupted time series. Country-level weekly data on deaths were fitted to the Poisson mixed linear model to estimate excess deaths. Based on this estimate, the percentage of excess deaths above the baseline during the pandemic (week 11 in 2020 to week 15 in 2022) (when public health interventions were in place) and during the post-pandemic period (week 16 in 2022 to week 52 in 2022) were calculated. These results were fitted to the linear regression model to determine any potential relationship between mortality during these two periods. The model used in this study had high predictive value (adjusted R The most successful countries in terms of protective measures also experienced the highest mortality rates after restrictions were lifted. The model used in this study clearly shows a measure of bidirectional mortality displacement that is sufficiently clear to mask any impact of long COVID on overall mortality. Results from this study also seriously impact previous cost-benefit analyses of pandemic prevention measures, since, according to the current model, 12.2% (95% CI: 8.3, 16.1) of the gains achieved in pandemic containment were lost after restrictions were lifted.

Identifiants

pubmed: 37672832
pii: S0033-3506(23)00287-1
doi: 10.1016/j.puhe.2023.08.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

193-201

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

M P Walkowiak (MP)

Department of Preventive Medicine, Poznan University of Medical Sciences, Poznań, Poland. Electronic address: marcinwalkowiak@ump.edu.pl.

J Domaradzki (J)

Department of Social Sciences and Humanities, Poznan University of Medical Sciences, Poznań, Poland. Electronic address: jandomar@ump.edu.pl.

D Walkowiak (D)

Department of Organization and Management in Health Care, Poznan University of Medical Sciences, Poznań, Poland. Electronic address: dariuszwalkowiak@ump.edu.pl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH